Harmony Biosciences Holdings, Inc. HRMY
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company focused on the development and commercialization of therapies for neurological disorders. Its lead product, WAKIX, is a molecule with a novel mechanism of action that increases histamine signaling in the brain by binding to H3 receptors, pr…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees293
TickerHRMY
Statistics
Market Cap$1.95B
Revenue (TTM)$868.5M
Net Income$158.7M
Net Margin18.3%
EPS$2.71
P/E14.19
P/S2.27
P/B2.24
EV/EBITDA7.27
ROE17.9%
Dividend Yield—
Price$33.72
Data: Twelve Data · Revenue = mcap / P/S